Publications by authors named "Michael Reardon"

Claim this Profile
F
Five-Year Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Women: A Systematic Review and Meta-Analysis.
Seth E M Wolf, John A Kucera, Alexander C Gregg, Antonino Di Franco, Mohamed Rahouma, Michael Reardon

Eur J Cardiothorac Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year Outcomes of Transcatheter Aortic Valve Replacement Versus Surgery in Low-risk Aortic Stenosis: Insights from the Evolut Low Risk Trial.
Saliha Erdem, Sachin S Goel, Michael J Reardon

Heart Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter Tricuspid Valve Replacement in a Heart Transplant Recipient.
Chloe Kharsa, Isadora Sande Mathias, Hassaan Bin Arshad, Catherine Teng, Nadeen N Faza, Michael Reardon

JACC Case Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Month Outcomes of a Supra-Annular Transcatheter Mitral Valve Replacement: An Early Feasibility Study.
Philippe Généreux, Krzysztof Wróbel, Vlasis Ninios, Marek Grygier, Naeem Tahirkheli, Michael J Reardon

JACC Cardiovasc Interv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Hemangioma.
Marvin D Atkins, Michael J Reardon

Ann Thorac Surg· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes of the Early-Generation Intrepid Transapical Transcatheter Mitral Valve Replacement System.
Gilbert H L Tang, Vivek Rajagopal, Paul Sorajja, Tanvir Bajwa, Robert Gooley, Michael J Reardon

EuroIntervention· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thirty-day outcomes of a novel biomimetic balloon-expandable transcatheter heart valve in patients with small aortic annuli.
Ole De Backer, Arif A Khokhar, Gintautas Bieliauskas, Azeem Latib, Rishi Puri, Michael J Reardon

EuroIntervention· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging of Cardiac Adverse Remodeling in Moderate or Severe Aortic Regurgitation.
Maan Malahfji, Duc T Nguyen, Priyanka Bhugra, Valentina Crudo, Mujtaba Saeed, Michael J Reardon

JACC Cardiovasc Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tricuspid Transcatheter Edge-to-Edge Repair Versus Medical Management for Tricuspid Regurgitation: A Systematic Review and Meta-Analysis.
Mangesh Kritya, Chloe Kharsa, Sahar Samimi, Gal Sella, Joe Aoun, Michael J Reardon

Catheter Cardiovasc Interv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter edge-to-edge repair for the management of secondary mitral regurgitation - CRT 2025 Beyond the Guidelines.
Dan Haberman, Michael J Reardon, Gregg W Stone, Chet Rihal, Tiziana Claudia Aranzulla

Cardiovasc Revasc Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Remodeling and Outcomes of Patients With Combined Aortic and Mitral Regurgitation.
Maan Malahfji, Mujtaba Saeed, Duc T Nguyen, Yodying Kaolawanich, Hossam Lababidi, Michael J Reardon

JACC Cardiovasc Imaging· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Outcomes and Quality of Life After CABG or PCI for Multivessel Disease: The FAME 3 Trial.
Mark A Hlatky, Victoria Y Ding, Frederik M Zimmermann, Zsolt Piróth, Giedrius Davidavičius, Michael J Reardon

J Am Coll Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uniform Safety and Excellent Performance of Pressure-Regulated Deployment of Transcatheter Aortic Valves.
Afik Snir, Michael K Wilson, Bianca Coelho, Andrew Moussad, Christopher Naoum, Michael J Reardon

Struct Heart· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: Did the ACURATE neo2 Fail or Did We Fail the Valve?
Aakriti Gupta, Michael J Reardon, Tarun Chakravarty, Raj R Makkar

J Am Coll Cardiol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Natriuretic Peptide and Prior Hospitalization in Patients With Severe Mitral Regurgitation: COAPT Trial.
Sachin S Goel, Ashrith Guha, JoAnn Lindenfeld, William T Abraham, Saibal Kar, Michael J Reardon

Circ Cardiovasc Interv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valve Underexpansion and Clinical Outcomes With ACURATE neo2: Findings From the ACURATE IDE Trial.
Raj R Makkar, Tarun Chakravarty, Aakriti Gupta, Osama Soliman, Eric Gnall, Michael J Reardon

J Am Coll Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Management for Primary Malignant Cardiac Tumors: Contemporary Trends and Outcomes.
Kanhua Yin, Yesh Datar, J Dylan Pate, Michael J Reardon, Nikola Dobrilovic

Heart Lung Circ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Xiao et al.
Joseph F Sabik, Vivek Rao, Francois Dagenais, Michael J Reardon,

Eur J Cardiothorac Surg· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial.
Raj R Makkar, Ravi K Ramana, Eric Gnall, Basel Ramlawi, Wen Cheng, Michael J Reardon

Lancet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Does the TAVR Universe Best Expand?
Sachin S Goel, Michael J Reardon

JACC Cardiovasc Interv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk.
Steven J Yakubov, Nicolas M Van Mieghem, Jae K Oh, Saki Ito, Kendra J Grubb, Michael J Reardon

J Am Coll Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome.
Kuniaki Takahashi, Hisao Otsuki, Frederik M Zimmermann, Victoria Y Ding, Zsolt Piroth, Michael J Reardon

JACC Cardiovasc Interv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Mitral Valve Repair vs Replacement After Failed Mitral Transcatheter Edge-to-Edge Repair: The CUTTING-EDGE Registry.
Mateo Marin-Cuartas, Jagdip Kang, Thilo Noack, Manuela de la Cuesta, Markus Krane, Michael J Reardon

JACC Cardiovasc Interv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Aortic Valve Replacement For Bicuspid And Tricuspid Valve Disease: 7-Year Outcomes In >1100 Patients.
Louis Labrousse, Michael G Moront, Francois Dagenais, Michael J Reardon, G Michael Deeb

Port J Card Thorac Vasc Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcatheter aortic valve replacement explant for self-expandable valves.
Fatima Qamar, Michael J Reardon, Marvin Atkins

Ann Cardiothorac Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis